|
CL2025003861A1
(es)
|
|
Formulaciones farmacéuticas de un agonista del receptor de amilina y un agonista del receptor de glp-1 que comprenden una ciclodextrina.
|
|
BR102023014872A2
(https=)
|
|
|
|
BR102023012440A2
(https=)
|
|
|
|
BR102023010976A2
(https=)
|
|
|
|
BR102023009641A2
(https=)
|
|
|
|
BR102023008688A2
(https=)
|
|
|
|
BR102023007252A2
(https=)
|
|
|
|
BR102023005164A2
(https=)
|
|
|
|
BR102023001877A2
(https=)
|
|
|
|
BR202022009269U2
(https=)
|
|
|
|
BR202022005961U2
(https=)
|
|
|
|
BR202022001779U2
(https=)
|
|
|
|
BR202022000931U2
(https=)
|
|
|
|
CN307045785S
(https=)
|
|
|
|
BY13164U
(https=)
|
|
|
|
BY13135U
(https=)
|
|
|
|
CN307044693S
(https=)
|
|
|
|
BY13140U
(https=)
|
|
|
|
CN307044673S
(https=)
|
|
|
|
BY13162U
(https=)
|
|
|
|
CN307044581S
(https=)
|
|
|
|
CN307044538S
(https=)
|
|
|
|
CN307044507S
(https=)
|
|
|
|
CN307045920S
(https=)
|
|
|
|
BY23976C1
(https=)
|
|
|